Resistin, an adipokine with potent proinflammatory properties

Journal of Immunology

Volumn 174, Issue 9, 2005, Pages 5789-5795

  Bokarewa, Maria ^a,c   Nagaev, Ivan ^a   Dahlberg, Leif ^b   Smith, Ulf ^a   Tarkowski, Andrej ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c Dept Rheumatol/Inflammation Res ^*  (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; PARTHENOLIDE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GEL MOBILITY SHIFT ASSAY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; INJECTION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; POSITIVE FEEDBACK; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID LEVEL;

EID: 17844392652     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.9.5789     Document Type: Article

References (25)

1. Steppan, C. M., E. J. Brown, C. M. Wright, S. Bhat, R. R. Banerjee, C. Y. Dai, G. H. Enders, D. G. Silberg, X. Wen, G. D. Wu, et al. 2001. A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. USA 98:502.
2. Steppan, C. M., S. T. Bailey, S. Bhat, E. J. Brown, R. R. Banerjee, C. M. Wright, H. R. Patel, R. S. Ahima, and M. A. Lazar. 2001. The hormone resistin links obesity to diabetes. Nature 409:307.
3. Holcomb, I. N., R. C. Kabakoff, B. Chan, T. W. Baker, A. Gurney, W. Henzel, C. Nelson, H. B. Lowman, B. D. Wright, N. J. Skelton, et al. 2000. FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO (Eur. Mol. Biol. Organ) J. 19:4046.
4. Patel, L., A. C. Buckels, I. J. Kinghorn, P. R. Murdock, J. D. Holbrook, C. Plumpton, C. H. Macphee, and S. A. Smith. 2003. Resistin is expressed in human macrophages and directly regulated by PPAR-γ activators. Biochem. Biophys. Res. Commun. 300:472.
5. Nagaev, I., and U. Smith. 2001. Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem. Biophys. Res. Commun. 285:561.
6. Lu, S. C., W. Y. Shieh, C. Y. Chen, S. C. Hsu, and H. L. Chen. 2002. Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 530:158.
7. Furuhashi, M., N. Ura, K. Higashiura, H. Murakami, and K. Shimamoto. 2003. Circulating resistin levels in essential hypertension. Clin. Endocrinol. 59:507.
8. Lee, J. H., J. L. Chan, N. Yiannakouris, M. Kontogianni, E. Estrada, R. Seip, C. Orlova, and C. S. Mantzoros. 2003. Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 88:4848.
9. Banerjee, R. R., and M. A. Lazar. 2003. Resistin: molecular history and prognosis. J. Mol. Med. 81:218.
10. Hartman, H. B., X. Hu, K. X. Tyler, C. K. Dalal, and M. A. Lazar. 2002. Mechanisms regulating adipocyte expression of resistin. J. Biol. Chem. 277:19754.
11. McTernan, P. G., F. M. Fisher, G. Valsamakis, R. Chetty, A. Harte, C. L. McTernan, P. M. Clark, S. A. Smith, A. H. Barnett, and S. Kumar. 2003. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J. Clin. Endocrinol. Metab. 88:6098.
12. Degawa-Yamauchi, M., J. E. Bovenkerk, B. E. Juliar, W. Watson, K. Kerr, R. Jones, Q. Zhu, and R. V. Considine. 2003. Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 88:5452.
13. Kaser, S., A. Kaser, A. Sandhofer, C. F. Ebenbichler, H. Tilg, and J. R. Patsch. 2003. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 309:286.
14. Fasshauer, M., J. Klein, S. Neumann, M. Eszlinger, and R. Paschke. 2001. Tumor necrosis factor α is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 288:1027.
15. Rajala, M. W., Y. Lin, M. Ranalletta, X. M. Yang, H. Qian, R. Gingerich, N. Barzilai, and P. E. Scherer. 2002. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-α in adipose tissue. Mol. Endocrinol. 16:1920.
16. Arnett, F. C., S. M. Edworthy, D. A. Bloch, D. J. McShane, J. F. Fries, N. S. Cooper, L. A. Harley, S. R. Kaplan, M. H. Liang, H. S. Luthra, et al. 1988. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31:315.
17. Pullerits, R., I. M. Jonsson, M. Verdrengh, M. Bokarewa, U. Andersson, H. Erlandsson-Harris, and A. Tarkowski. 2003. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis Rheum. 48:1693.
18. Schubert, D., B. Maier, L. Morawietz, V. Krenn, and T. Kamradt. 2004. Immunization with glucose-6-phosphate isomerase induces T cell-dependent peripheral polyarthritis in genetically unaltered mice. J. Immunol. 172:4503.
19. Deng, G. M., I. M. Nilsson, M. Verdrengh, L. V. Collins, and A. Tarkowski. 1999. Intra-articularly localized bacterial DNA containing CpG motifs induces arthritis. Nat. Med. 5:702.
20. Weinblatt, M. E., E. C. Keystone, D. E. Furst, L. W. Moreland, M. H. Weisman, C. A. Birbara, L. A. Teoh, S. A. Fischkoff, and E. K. Chartash. 2003. Adalimumab, a fully human anti-tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 48:35.
21. Weinblatt, M. E., J. M. Kremer, A. D. Bankhurst, K. J. Bulpitt, R. M. Fleischmann, R. I. Fox, C. G. Jackson, M. Lange, and D. J. Burge. 1999. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N. Engl. J. Med. 340:253.
22. Maini, R., E. W. St. Clair, F. Breedveld, D. Furst, J. Kalden, M. Weisman, J. Smolen, P. Emery, G. Harriman, M. Feldmann, et al. 1999. Infliximab (chimeric anti-tumour necrosis factor αmonoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial: ATTRACT Study Group. Lancet 354:1932.
23. Bokarewa, M., and A. Tarkowski. 2003. Local infusion of infliximab for the treatment of acute joint inflammation. Ann. Rheum. Dis. 62:783.
24. Verma, S., S. H. Li, C. H. Wang, P. W. Fedak, R. K. Li, R. D. Weisel, and D. A. Mickle. 2003. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108:736.
25. Schaffler, A., A. Ehling, E. Neumann, H. Herfarth, I. Tarner, J. Scholmerich, U. Muller-Ladner, and S. Gay. 2003. Adipocytokines in synovial fluid. J. Am. Med. Assoc. 290:1709.